Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 10Phase 1 6Phase 3 3Phase 2/3 1Phase 1/2 1

Status

Recruiting 3Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Neoplasms 2012Carcinoma, Non-Small-Cell Lung 1228Breast Neoplasms 1215Leukemia, Myeloid, Acute 967Neoplasm Metastasis 902Melanoma 778Colorectal Neoplasms 752Multiple Myeloma 725Lymphoma 725Ovarian Neoplasms 675Pancreatic Neoplasms 665Lymphoma, Non-Hodgkin 659Prostatic Neoplasms 657Recurrence 637Precursor Cell Lymphoblastic Leukemia-Lymphoma 585Lung Neoplasms 560Leukemia, Lymphocytic, Chronic, B-Cell 555Glioblastoma 527Leukemia 486Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 419Brain Neoplasms 415Squamous Cell Carcinoma of Head and Neck 389Stomach Neoplasms 387Carcinoma, Renal Cell 385Myelodysplastic Syndromes 382Carcinoma, Hepatocellular 368Advanced Solid Tumors 357Lymphoma, Mantle-Cell 345Glioma 343

Interventions

enzalutamide 2gallium 68 PSMA-11 1entinostat 1bicalutamide 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Prostate Adenocarcinoma × Clear all
NCT06044857 2026-04-14

PSMA PET Response Guided SabR in High Risk Pca

University of Texas Southwestern Medical Center

Phase 1 Recruiting
20 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT04943536 2026-02-27

BiolenRT

Alessa Therapeutics Inc.

Phase 1 Active not recruiting
20 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT06257693 2026-02-27

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

Alessa Therapeutics Inc.

Phase 1 Recruiting
56 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT06736054 2024-12-16

A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer

Hoag Memorial Hospital Presbyterian

Phase 1 Recruiting
8 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT03829930 2021-08-02

Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer

George Washington University

Phase 1 Terminated
6 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT01219790 2016-04-19

GEMO

Institut Cancerologie de l'Ouest

Phase 1 Completed
30 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡